Radiolife
Radiolife is pioneering transformative healthcare innovation by leveraging cutting-edge radio frequency technology and AI to develop fast, accessible diagnostics. Their investigational diagnostic medical device aims to deliver rapid, accurate, and cost-effective results, enabling earlier and more targeted interventions for improved patient outcomes. With a vision to democratize healthcare, Radiolife is committed to making advanced diagnostics accessible to all, thereby enhancing global healthcare practices and fostering healthier communities.
Radiolife
Radiolife is pioneering transformative healthcare innovation by leveraging cutting-edge radio frequency technology and AI to develop fast, accessible diagnostics. Their investigational diagnostic medical device aims to deliver rapid, accurate, and cost-effective results, enabling earlier and more targeted interventions for improved patient outcomes. With a vision to democratize healthcare, Radiolife is committed to making advanced diagnostics accessible to all, thereby enhancing global healthcare practices and fostering healthier communities.
TL;DR
Founded: 2021
Core tech: Radio-frequency (RF) + AI reagentless diagnostics
Flagship/device: Cube Scan (investigational diagnostic device)
Stage / funding: Pre-seed / currently raising
Notable backer: The Roux Institute at Northeastern University
Company Overview
Problem Domain
Point-of-care infectious disease and biomarker diagnostics
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
Participation in The Roux Institute Future of Healthcare Founder Residency; company reported healthcare innovation grant and program support.
Investor Signal
“The Roux Institute at Northeastern University listed as lead/pre-seed investor and program partner”